Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 721 AL 735

The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease

Trojan V, Landa L, Šulcová A, Slíva J, Hřib R.

Biomolecules. 2023 Sep 26;13(10):1446. doi: 10.3390/biom13101446.

The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design

Tundo GR, Grasso G, Persico M, Tkachuk O, Bellia F, Bocedi A, Marini S, Parravano M, Graziani G, Fattorusso C, Sbardella D.

Biomolecules. 2023 Oct 7;13(10):1492. doi: 10.3390/biom13101492.

Recent Computational Advances Regarding Amyloid-β and Tau Membrane Interactions in Alzheimer's Disease

Nguyen PH, Derreumaux P.

Molecules. 2023 Oct 13;28(20):7080. doi: 10.3390/molecules28207080.

Ethnic, Botanic, Phytochemistry and Pharmacology of the Acorus L. Genus: A Review

Zhao Y, Li J, Cao G, Zhao D, Li G, Zhang H, Yan M.

Molecules. 2023 Oct 16;28(20):7117. doi: 10.3390/molecules28207117.

Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer's Disease: A Recent Systematic Review

Munteanu C, Iordan DA, Hoteteu M, Popescu C, Postoiu R, Onu I, Onose G.

Int J Mol Sci. 2023 Oct 23;24(20):15481. doi: 10.3390/ijms242015481.

INPP5D/SHIP1: Expression, Regulation and Roles in Alzheimer's Disease Pathophysiology

Olufunmilayo EO, Holsinger RMD.

Genes (Basel). 2023 Sep 23;14(10):1845. doi: 10.3390/genes14101845.

The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease

Mehta N, Dangas K, Ditmarsch M, Rensen PCN, Dicklin MR, Kastelein JJP.

Pharmacol Res. 2023 Nov;197:106972. doi: 10.1016/j.phrs.2023.106972. Epub 2023 Oct 28.

GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports

Ingannato A, Bessi V, Chiari A, Salvatori D, Bagnoli S, Bedin R, Ferrari C, Sorbi S, Nacmias B.

J Alzheimers Dis. 2023;96(2):767-775. doi: 10.3233/JAD-230689.

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer's disease: A systematic review

Chowdhury S, Chowdhury NS.

Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231209839. doi: 10.1177/03946320231209839.

Network pharmacology and molecular docking approaches predict the mechanisms of Corididius chinensis in treating manganese-induced nervous system diseases: A review

Zhang M, Lou H, Ma J, Xiong K, Hou X.

Medicine (Baltimore). 2023 Oct 27;102(43):e35669. doi: 10.1097/MD.0000000000035669.

Differential roles of regulatory T cells in Alzheimer's disease

Jafarzadeh A, Sheikhi A, Jafarzadeh Z, Nemati M.

Cell Immunol. 2023 Nov-Dec;393-394:104778. doi: 10.1016/j.cellimm.2023.104778. Epub 2023 Oct 29.

Passive Immunotherapies Targeting Amyloid-β in Alzheimer's Disease: A Quantitative Systems Pharmacology Perspective

Marković M, Milošević J, Wang W, Cao Y.

Mol Pharmacol. 2023 Dec 15;105(1):1-13. doi: 10.1124/molpharm.123.000726.

Exploring concepts and trends in informal caregiver burden: systematic review using citation network and content analysis

Chien SC, Chang YH, Yen CM, Onthoni DD, Wu IC, Hsu CC, Chiou HY, Chung RH.

Aging Clin Exp Res. 2023 Dec;35(12):2873-2885. doi: 10.1007/s40520-023-02582-w. Epub 2023 Nov 1.

Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics

Lepiarz-Raba I, Gbadamosi I, Florea R, Paolicelli RC, Jawaid A.

Transl Neurodegener. 2023 Oct 31;12(1):48. doi: 10.1186/s40035-023-00382-w.

The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges

He J, Liu F, Xu T, Ma J, Yu H, Zhao J, Xie Y, Luo L, Yang Q, Lou T, He L, Sun D.

Biomed Pharmacother. 2023 Dec;168:115807. doi: 10.1016/j.biopha.2023.115807. Epub 2023 Oct 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias